Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-166,460
Closed -$559K 67
2024
Q3
$559K Hold
166,460
0.04% 66
2024
Q2
$907K Hold
166,460
0.06% 70
2024
Q1
$882K Sell
166,460
-1,208
-0.7% -$6.88K 0.06% 68
2023
Q4
$1.05M Hold
167,668
0.09% 55
2023
Q3
$801K Hold
167,668
0.07% 66
2023
Q2
$1M Sell
167,668
-20,710
-11% -$166K 0.08% 63
2023
Q1
$1.4M Buy
188,378
+155,356
+470% +$1.55M 0.1% 57
2022
Q4
$409K Sell
33,022
-155,778
-83% -$2.73M 0.04% 61
2022
Q3
$3.89M Buy
188,800
+75,724
+67% +$2.1M 0.34% 40
2022
Q2
$3.13M Buy
+113,076
New +$3.87M 0.22% 55
2021
Q3
Sell
-56,694
Closed -$4.82M 106
2021
Q2
$4.82M Sell
56,694
-47,919
-46% -$4.37M 0.32% 48
2021
Q1
$8.27M Buy
104,613
+8,142
+8% +$529K 0.62% 41
2020
Q4
$5.61M Sell
96,471
-28,075
-23% -$1.32M 0.66% 33
2020
Q3
$4.22M Buy
124,546
+30,247
+32% +$1.15M 0.94% 27
2020
Q2
$4.35M Buy
94,299
+38,219
+68% +$1.06M 0.6% 30
2020
Q1
$886K Sell
56,080
-29,697
-35% -$707K 0.22% 46
2019
Q4
$2.35M Buy
85,777
+53,560
+166% +$1.43M 0.42% 43
2019
Q3
$947K Hold
32,217
0.29% 43
2019
Q2
$925K Hold
32,217
0.26% 47
2019
Q1
$1.35M Sell
32,217
-1,360
-4% -$48.9K 0.39% 37
2018
Q4
$1.04M Sell
33,577
-9,696
-22% -$361K 0.57% 33
2018
Q3
$1.88M Buy
43,273
+4,587
+12% +$130K 0.83% 23
2018
Q2
$638K Hold
38,686
0.29% 53
2018
Q1
$716K Buy
+38,686
New +$730K 0.33% 44

Other funds holding AFMD

Eversept Partners's AFMD Position: Q4 2024 in Review

Eversept Partners sold out of Affimed (AFMD) in Q4 2024, closing a stake of 166,460 shares — an estimated $559K sold.

Eversept Partners first reported a position in AFMD in Q1 2018 and held it in 24 quarters. The position peaked at $8.27M in Q1 2021. 37 funds tracked by Wall St. Rank hold AFMD as of Q4 2024.

  • Eversept Partners reported no remaining Affimed position as of Q4 2024 after selling out during the quarter.
  • Eversept Partners sold 166,460 Affimed shares in Q4 2024, an estimated $559K.
  • Eversept Partners first reported a position in Affimed in Q1 2018 and held it in 24 quarters.
  • Eversept Partners's Affimed position peaked at $8.27M in Q1 2021.
  • 37 funds tracked by Wall St. Rank held Affimed as of Q4 2024.

Based on Eversept Partners's 13F filing for Q4 2024, filed 14 Feb 2025.